Dihydropyrimidine dehydrogenase gene (DPYD) polymorphism Among Caucasian and non-caucasian patients with 5-FU- and capecitabine-related toxicity using Full sequencing of DPYD

Cancer Genomics and Proteomics

Volumn 10, Issue 2, 2013, Pages 89-92

  Saif, Muhammad Wasif ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 FU; Capecitabine; DPD; DPYD; Pharmacogenetics

Indexed keywords

CAPECITABINE; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CAUCASIAN; COLON CANCER; CONTROLLED STUDY; DRUG SCREENING; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HAND FOOT SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; PHARMACOGENETICS;

EID: 84876942704     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Saif MW, Syrigos K, Mehra R, Mattison LK and Diasio RB: Dihydropyrimidine dehydrogenase deficiency (DPD) in GI malignancies: Experience of 4-years. Pak J Med Sci Q 23(6):832-839, 2007.
2. Mattison LK, Fourie J, Desmond RA, Modak A, Saif MW and Diasio RB: Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians. Clin Cancer Res 12(18):5491-5495, 2006. (Pubitemid 44497265)
3. Diasio RB: The role of dihydropyrimidine dehydrogenase (DPD) modulation in 5-FU pharmacology. Oncology (Williston Park) 12:23-27, 1998. (Pubitemid 28536404)
4. Saif MW, Ezzeldin H, Vance K, Sellers S and Diasio RB: DPYD2A mutation: the most common mutation associated with DPD deficiency. Cancer Chemother Pharmacol 60(4):503-507, 2007. (Pubitemid 47084259)
5. Saif MW, Elfiky A and Diasio R: Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine. Clin Colorectal Cancer 6(3):219-223, 2006. (Pubitemid 44596772)
6. http://www.myriadtests.com/provider/doc/TheraGuide-5-FU-Tehcnical- Specifications.pdf
7. Saif MW and Sandoval A: Atypical hand-and-foot syndrome in an African American patient treated with capecitabine with normal DPD activity: is there an ethnic disparity? Cutan Ocul Toxicol 27(4):311-315, 2008. (Pubitemid 352767481)
8. Saif MW, Mattison L, Carollo T, Ezzeldin H and Diasio RB: Dihydropyrimidine dehydrogenase deficiency in an Indian population. Cancer Chemother Pharmacol 58(3):396-401, 2006. (Pubitemid 43800744)
9. Ezzeldin H, Johnson MR, Okamoto Y and Diasio RB: Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicity. Clin Cancer Res 9:3021-3028, 2003. (Pubitemid 36993262)
10. Ridge SA, Sludden J, Brown O, Robertson L, Wei X and Sapone A: Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects. Br J Clin Pharmacol 46:151-156, 1998. (Pubitemid 28342786)
11. Celik I, Kars A, Guc D, Tekuzman G and Ruacan S: Dihydropyrimidine dehydrogenase enzyme deficiency: clinical and genetic assessment of prevalence in Turkish cancer patients. Cancer Invest 20:333-319, 2002.
12. Wei X, McLeod HL, McMurrough J, Gonzalez FJ and Fernandez-Salguero P: Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J Clin Invest 3:610-5, 1996. (Pubitemid 26349163)
13. van Kuilenburg ABP, Meinsma R, Beke E, Bobba B, Boffi P and Enns GM: Identification of three novel mutations in the dihydropyrimidine dehydrogenase gene associated with altered premRNA splicing or protein function. Biol Chem 386:319-324, 2005. (Pubitemid 41447594)
14. Van Kuilenburg AB: Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. Eur J Cancer 40:939-950, 2004. (Pubitemid 38496249)
15. van Kuilenburg ABP, Dobritzsch D, Meinsma R, Haasjes J, Waterham HR and Nowaczyk MJM: Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure. Biochem J 364:157-163, 2002. (Pubitemid 34538958)
16. Hsiao HH, Yang MY, Chang JG, Liu YC, Liu TC and Chang CS: Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population. Cancer Chemother Pharmacol 53:445-451, 2004.
17. Ezzeldin H, Johnson MR, Okamoto Y and Diasio RB: Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicity. Clin Cancer Res 9:3021-3028, 2003. (Pubitemid 36993262)
18. Vreken P, van Kuilenburg ABP, Meinsma R, De Abreu RA and Van Gennip AH: Dihydropyrimidine dehydrogenase (DPD) deficiency: identification and expression of missense mutations C29R, R886H and R235W. Hum Genet 101:333-338, 1997. (Pubitemid 28197529)
19. Ogura K, Ohnuma T, Minamide Y, Mizuno A, Nishiyama T and Nagashima S: Dihydropyrimidine dehydrogenase activity in 150 healthy Japanese volunteers and identification of novel mutations. Clin Cancer Res 11:5104-5111, 2005. (Pubitemid 41003694)
20. Wei X, Elizondo G, Sapone A, McLeod HL, Raunio H, Fernandez-Salquero P and Gonzalez FJ: Characterization of human dihydropyrimidine dehydrogenase gene. Genomics 51:391-400, 1998. (Pubitemid 28413205)
21. Seck K, Riemer S, Kates R, Ulrich T, Lutz V and Harbeck N: Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in a cohort of Caucasian individuals. Clin Cancer Res 11:5886-5892, 2005. (Pubitemid 41170317)
22. Yamaguchi K, Arai Y, Kanda Y and Akagi K: Germline mutation of dihydropyrimidine dehydrogenase gene among a Japanese population in relation to toxicity to 5-fluorouracil. Jpn J Cancer Res 92:337-342, 2001. (Pubitemid 32288297)
23. Vreken P, van Kuilenburg ABP, Meinsma R, Haasjes J, Waterham HR and Nowaczyk MJJ: Dihydropyrimidine dehydrogenase deficiency: a novel mutation and expression of missense mutations in E. Coli. J Inherit Metab Dis 21:276-279, 1997.
24. Johnson MR, Wang K and Diasio RB: Profound dihydro-pyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype. Clin Cancer Res 8:768-774, 2002. (Pubitemid 34742106)
25. http://www.fda.gov/medwatch/SAFETY/2003/mar03.htm.
26. Saif MW and Diasio R: Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency? Clin Colorectal Cancer 5(5):359-362, 2006. (Pubitemid 43280067)
27. Van Kuilenburg AB: Screening for dihydropyrimidine dehydrogenase deficiency: to do or not to do, that's the question. Cancer Invest 24:215-217, 2006.